阿尔茨海默氏症疾病的炎症方面
Pablo Botella Lucena1, Michael T Heneka2,3
1Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 6, Avenue du Swing, Belvaux, L-4367, Esch-Belval, Luxembourg.
Acta neuropathologica
|August 28, 2024
概括
阿尔茨海默氏病 (AD) 涉及神经炎症,其中微质细胞和星球细胞与粉样β和团等核心病理一起发挥关键作用. 了解这些细胞相互作用对于开发有效的AD疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是神经退行和认知衰退的主要原因.
- 神经炎症越来越被认为是AD病变发生的一个关键因素.
- 虽然微质细胞得到了很好的研究,但其他脑细胞也会导致AD的炎症环境.
研究的目的:
- 审查微质细胞和星球细胞在阿尔茨海默病中的炎症作用.
- 为了检查这些质细胞和AD病理 (粉样β和tau) 之间的相互作用.
- 讨论调节细胞死亡对AD慢性神经炎症的影响.
主要方法:
- 在阿尔茨海默病中神经炎症的文献综述.
- 在AD病变发生过程中细胞相互作用的分析.
- 讨论受调节的细胞死亡机制及其炎症后果.
主要成果:
- 微质细胞和星体细胞是AD相关的神经炎症中的关键细胞参与者.
- 这些质细胞与粉样β斑块和tau团相互作用.
- 调节的细胞死亡途径显著影响了AD的慢性炎症环境.
结论:
- 对阿尔茨海默症神经炎症的全面理解需要考虑超出微质细胞之外的多种细胞类型.
- 向质细胞相互作用和炎症途径对阿尔茨海默病具有治疗潜力.
- 未来的AD研究应该将质生物学,核心病理和细胞死亡机制纳入新型策略.
相关概念视频
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
Role of Neurotransmitters in Memory
485
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
485
Inflammation
53.2K
Overview
53.2K


